Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Sumitomo SMFG Stock Strong Buy Rating Buying Pressure 20260415 Nuveen NMS Stock Insider Ownership Breakdown Watch 20260415 The investment merits of VTI over SCHD for longterm wealth accumulation rest upon several interconnected factors that warrant careful examination Generative AI Enterprise Adoption Utility Gap and Operational Risk Analysis Is Nutex Health NUTX stock fairly priced today 311 20260423 PRKS United slides 34 following sharp Q4 2025 EPS miss that lags analyst estimates by nearly 50 Vivid Seats SEAT Stock Why Institutions Watch It Underperforming 20260420 Tencent and Alibaba Sales Miss Estimates as AI Monetization Efforts Face Headwinds Jim Cramer on Charles Schwab I Think the Markets Misjudging This One Lichen LICN Declines 1561 Amid Market Weakness 20260515 Xenon XENE Slides 294 as Selling Pressure Mounts 20260515 General Motors Unveils AllElectric Cadillac Vistiq with 300Mile Range PrimeEnergy PNRG Stock Up 139 Key Resistance at 26775 20260514 The Pitfalls of Chasing ShortTerm Returns A Cautionary Perspective for Investors Tulsi Gabbard Resigns as US Director of National Intelligence Citing Family Health Kardigan Files for IPO to Advance Heart Disease Drug Pipeline ADP Private Payrolls Rise 109000 in April Exceeding Expectations Amid Stable Labor Market Warren Buffetts Tiny Purchase in March Berkshire Filing May Reveal the Mystery Investment Ebola Outbreak Update Healthcare Sector Under Scrutiny Amid Fresh Cases Dave Inc DAVE Q1 2026 Earnings EPS Surges 37 Above Estimates Stock Pulls Back LEGT Q1 2026 Earnings SPAC Reports Positive EPS Amid No Revenue Stock Slightly Up ISSC Q1 2026 Earnings EPS Surges Past Estimates Driving Stock Higher Tenaya Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Steady Pipeline Progress ELTX Q1 2026 Earnings Widerthanexpected loss as clinicalstage biotech advances pipeline EFOI Q4 2024 Earnings Narrowing Losses and Positive Stock Reaction Despite Limited Disclosure KFIIR Rights Decline Further Testing Critical Support at 010 Zai Lab ZLAB Slips 112 as Biotech Sector Weighs on Shares Excelerate Energy EE Declines 358 as Shares Test Key Support Zone Minerva Neurosciences NERV Edges Lower as Stock Tests Key Support Zone VivoSim Labs Inc VIVS Edges Up 149 as It Tests Resistance at 143